TY - JOUR
T1 - Comorbidities of atopic dermatitis-what does the evidence say?
AU - Thyssen, Jacob P
AU - Halling, Anne-Sofie
AU - Schmid-Grendelmeier, Peter
AU - Guttman-Yassky, Emma
AU - Silverberg, Jonathan I
N1 - Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.
PY - 2023/5
Y1 - 2023/5
N2 - Atopic dermatitis (AD) is a common disease that is associated with atopic and nonatopic comorbidities. There has been a growing interest in this area of AD, because presence or risk of comorbidities can in many ways impact the management of patients with AD. Thus, some treatments for AD may improve its comorbidities as well, whereas others may increase their risk. In this review article, we discuss various comorbidities of AD mostly on the basis of the results of recent multiple systematic reviews and meta-analyses to update readers about this rapidly developing area of dermatology. We emphasize the important information provided by studies presenting both relative risk and absolute risk, and show that AD is associated with, among others, atopic comorbidities such as asthma, rhinitis, and food allergy, nonatopic comorbidities such as ocular, psychiatric, infectious, endocrine, autoimmune, and cardiovascular diseases, and certain cancers. Clinicians need to be aware of these and be cognizant about positive and negative effects of existing and new treatments for AD.
AB - Atopic dermatitis (AD) is a common disease that is associated with atopic and nonatopic comorbidities. There has been a growing interest in this area of AD, because presence or risk of comorbidities can in many ways impact the management of patients with AD. Thus, some treatments for AD may improve its comorbidities as well, whereas others may increase their risk. In this review article, we discuss various comorbidities of AD mostly on the basis of the results of recent multiple systematic reviews and meta-analyses to update readers about this rapidly developing area of dermatology. We emphasize the important information provided by studies presenting both relative risk and absolute risk, and show that AD is associated with, among others, atopic comorbidities such as asthma, rhinitis, and food allergy, nonatopic comorbidities such as ocular, psychiatric, infectious, endocrine, autoimmune, and cardiovascular diseases, and certain cancers. Clinicians need to be aware of these and be cognizant about positive and negative effects of existing and new treatments for AD.
KW - Humans
KW - Dermatitis, Atopic/epidemiology
KW - Comorbidity
KW - Asthma/epidemiology
KW - Food Hypersensitivity/epidemiology
KW - Rhinitis/complications
UR - http://www.scopus.com/inward/record.url?scp=85146092908&partnerID=8YFLogxK
U2 - 10.1016/j.jaci.2022.12.002
DO - 10.1016/j.jaci.2022.12.002
M3 - Review
C2 - 36621338
SN - 0091-6749
VL - 151
SP - 1155
EP - 1162
JO - The Journal of allergy and clinical immunology
JF - The Journal of allergy and clinical immunology
IS - 5
ER -